Newly published research finds that each successful breach can hurt the balance sheet of companies to the tune of hundreds of ...

The average net worth for 71-year-olds may surprise you. See how your savings compare and learn smart ways to avoid running ...

Postal Realty shows undervaluation at 11x AFFO, strong growth, high renewals, solid pipeline and balance sheet. Learn why ...

Vitamin D sits at the intersection of bone, muscle, immune health, and overall metabolism. Researchers have asked a simple ...

Berkshire Hathaway remains a core conservative holding, offering value amid an expensive market and robust Q3 operating ...

The transaction is structured with $30m (A$45.95m) in cash and $5m in Forrestania fully paid ordinary shares, with completion ...

A more powerful QuickBooks on the Intuit platform combines AI agents and trusted experts to unlock time savings and insights ...

Rates of colorectal cancer have been climbing in young people for a couple decades—recent reports from the American Cancer Society (ACS) have pinned it as the leading or second-leading cause of cancer ...

We can readily understand why investors are attracted to unprofitable companies. Indeed, Beyond Oil ( TSE:BOIL ) ...

Data from Phase 2 BESTOW trial demonstrated a favorable safety and tolerability profile, substantially reducing the metabolic, neurologic, and cardiovascular toxicities commonly associated with tacrol ...

Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH ...

FDA Approval to Advance Final FemBloc® Trial with Clear Pathway to Potentially Achieve U.S. FDA Approval - - $12 Million Financing Strengthens Balance Sheet and Extends Cash Runway - ATLANTA, Nov.